Spectral AI (NASDAQ:MDAI – Get Free Report) is projected to announce its Q3 2026 results after the market closes on Tuesday, November 10th. Analysts expect the company to post earnings of ($0.14) per share and revenue of $5.33 million for the quarter. Investors can check the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 5:00 PM ET.
Spectral AI (NASDAQ:MDAI – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01. The business had revenue of $3.52 million for the quarter, compared to analyst estimates of $4.17 million. On average, analysts expect Spectral AI to post ($0.50) EPS for the current fiscal year and ($0.31) EPS for the next fiscal year.
Spectral AI Price Performance
MDAI stock traded up $0.01 during trading hours on Tuesday, reaching $1.53. 57,236 shares of the stock were exchanged, compared to its average volume of 444,410. The firm’s 50-day moving average is $1.59 and its 200-day moving average is $1.70. The company has a market cap of $49.41 million, a price-to-earnings ratio of -4.39 and a beta of 1.21. Spectral AI has a 12 month low of $1.18 and a 12 month high of $2.97.
Analyst Upgrades and Downgrades
Several research firms have weighed in on MDAI. Wall Street Zen raised Spectral AI from a “sell” rating to a “hold” rating in a research report on Saturday, September 12th. Northland Securities raised shares of Spectral AI to a “strong-buy” rating in a report on Monday, July 27th. Finally, Weiss Ratings raised shares of Spectral AI from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, October 28th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $4.00.
View Our Latest Stock Report on MDAI
About Spectral AI
Spectral AI, Inc is a medical diagnostic technology company focused on using artificial intelligence and advanced imaging to support earlier, more objective assessment of wound healing. The company develops predictive diagnostic systems intended to help clinicians evaluate wounds and make treatment decisions.
Its principal product is the DeepView System, a noninvasive imaging and artificial intelligence platform designed to assess burn wounds and predict the likelihood that injured tissue will heal without surgical intervention.
Further Reading
- Five stocks we like better than Spectral AI
- Alphabet’s Golden Dome Talks Could Open a New Market, But How Much Is at Stake?
- Tempus AI Surges on Earnings Beat, But Can the Rally Last?
- MicroVision Pivots: Mapping New Ground Beyond Auto
- Are the Fears Around Alphabet’s Search Slowdown Warranted?
Receive News & Ratings for Spectral AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral AI and related companies with MarketBeat.com's FREE daily email newsletter.
